Profile | GDS4284 / 234359_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1134.36 | 76 |
GSM687648 | Patient 402 control | 726.307 | 69 |
GSM687653 | Patient 403 control | 1136.64 | 76 |
GSM687658 | Patient 404 control | 1337.03 | 78 |
GSM687663 | Patient 411 control | 975.218 | 73 |
GSM687668 | Patient 422 control | 994.419 | 74 |
GSM687673 | Patient 424 control | 801.843 | 70 |
GSM687678 | Patient 425 control | 967.722 | 73 |
GSM687683 | Patient 427 control | 979 | 73 |
GSM687688 | Patient 428 control | 918.461 | 73 |
GSM687695 | Patient 441 control | 714.06 | 69 |
GSM687699 | Patient 443 control | 1471.17 | 80 |
GSM687704 | Patient 444 control | 1046.67 | 75 |
GSM687707 | Patient 448 control | 813.211 | 71 |
GSM687712 | Patient 449 control | 849.024 | 72 |
GSM687719 | Patient 450 control | 1297.68 | 78 |
GSM687724 | Patient 451 control | 915.617 | 73 |
GSM687728 | Patient 452 control | 958.208 | 74 |
GSM687646 | Patient 401 treated 24h | 1143.12 | 76 |
GSM687649 | Patient 402 treated 24h | 867.034 | 72 |
GSM687665 | Patient 411 treated 24h | 939.449 | 73 |
GSM687651 | Patient 402 treated 4 weeks | 907.856 | 72 |
GSM687667 | Patient 411 treated 4 weeks | 707.843 | 68 |
GSM687670 | Patient 422 treated 24h | 933.912 | 72 |
GSM687671 | Patient 422 treated 4 weeks | 857.515 | 71 |
GSM687654 | Patient 403 treated 24h | 958.262 | 74 |
GSM687675 | Patient 424 treated 24h | 613.08 | 66 |
GSM687685 | Patient 427 treated 24h | 1021.98 | 74 |
GSM687656 | Patient 403 treated 4 weeks | 910.107 | 73 |
GSM687677 | Patient 424 treated 4 weeks | 613.218 | 66 |
GSM687687 | Patient 427 treated 4 weeks | 686.691 | 68 |
GSM687692 | Patient 428 treated 4h | 922.012 | 73 |
GSM687716 | Patient 449 treated 4h | 753.644 | 70 |
GSM687722 | Patient 450 treated 4h | 1217.71 | 77 |
GSM687680 | Patient 425 treated 24h | 1062.38 | 75 |
GSM687690 | Patient 428 treated 24h | 954.006 | 74 |
GSM687700 | Patient 443 treated 24h | 1544.94 | 81 |
GSM687705 | Patient 444 treated 24h | 701.186 | 69 |
GSM687714 | Patient 449 treated 24h | 832.298 | 72 |
GSM687721 | Patient 450 treated 24h | 1055.39 | 75 |
GSM687682 | Patient 425 treated 4 weeks | 1068.6 | 75 |
GSM687694 | Patient 428 treated 4 weeks | 827.589 | 71 |
GSM687702 | Patient 443 treated 4 weeks | 1447.27 | 79 |
GSM687718 | Patient 449 treated 4 weeks | 823.755 | 71 |
GSM687723 | Patient 450 treated 4 weeks | 1089.19 | 75 |
GSM687661 | Patient 404 treated 4h | 1817.41 | 82 |
GSM687710 | Patient 448 treated 4h | 710.296 | 70 |
GSM687726 | Patient 451 treated 4h | 1240 | 77 |
GSM687730 | Patient 452 treated 4h | 2211.59 | 87 |
GSM687660 | Patient 404 treated 24h | 1554.86 | 82 |
GSM687697 | Patient 441 treated 24h | 1058.18 | 75 |
GSM687709 | Patient 448 treated 24h | 755.545 | 70 |
GSM687725 | Patient 451 treated 24h | 1268.48 | 78 |
GSM687729 | Patient 452 treated 24h | 976.776 | 76 |
GSM687727 | Patient 451 treated 4 weeks | 1260.69 | 77 |
GSM687731 | Patient 452 treated 4 weeks | 1034.49 | 74 |